3613-73-8 (2,3,4,5-四氢-2,8-二甲基-5-[2-(6-甲基吡啶-3-基)乙基]-1H-吡啶并[4,3-b]吲哚,Dimebolin)

快速询单

结构式：

2,3,4,5-四氢-2,8-二甲基-5-[2-(6-甲基吡啶-3-基)乙基]-1H-吡啶并[4,3-b]吲哚MOL文件

CAS号：

3613-73-8

中文名称：

2,3,4,5-四氢-2,8-二甲基-5-[2-(6-甲基吡啶-3-基)乙基]-1H-吡啶并[4,3-b]吲哚

英文名称：

Dimebolin

分子式：

C₂₁H₂₅N₃

分子量：

319.443304777145

2,3,4,5-四氢-2,8-二甲基-5-[2-(6-甲基吡啶-3-基)乙基]-1H-吡啶并[4,3-b]吲哚(3613-73-8)名称与标识符

名称

中文别名：

2,3,4,5-四氢-2,8-二甲基-5-[2-(6-甲基吡啶-3-基)乙基]-1H-吡啶并[4,3-b]吲哚;丹吡芙蓉;

英文别名：

Dimebolin;2,3,4,5-Tetrahydro-2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-1H-pyrido[4,3-b]indole;2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-3,4-dihydro-1H-pyrido[4,3-b]indole;Dimebon;DIMEBON (DIMEBOLIN);Dimebone;aka latrepiridine;Dimeboline;Latrepirdine;Preparation 84;AKOS005146217;1H-Pyrido(4,3-b)indole, 2,3,4,5-tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridyl)ethyl)-;2,8-Dimethyl-5-(2-(6-methylpyridin-3-yl)ethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole;BCP9000611;DIMEBOLIN [MI];LATREPIRDINE HYDROCHLORIDE;AS-35091;Latrepirdine [USAN];MLS006013366;NS00070385;EX-A1498;D09917;2,8-Dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole #;DB11725;Latrepirdine [USAN:INN];NCGC00182554-02;BCPP000257;Latrepirdine (USAN/INN);LATREPIRDINE [INN];SMR001317776;HMS3327A20;3613-73-8;PF-01913539;UNII-OD9237K1Z6;BCP02189;SCHEMBL292354;HMS2200M23;2,8-Dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole;NCGC00182554-01;5-(2-{2,8-DIMETHYL-1H,2H,3H,4H,5H-PYRIDO[4,3-B]INDOL-5-YL}ETHYL)-2-METHYLPYRIDINE;LATREPIRDINE [MART.];BRN 0622478;MLS002264475;2,3,4,5-Tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridyl)ethyl)-1H-pyrido(4,3-b)indole;OD9237K1Z6;CHEMBL589390;2,8-Dimethyl-5-[2-(6-methyl-pyridin-3-yl)-ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole;AC-5146;MFCD00387540;FT-0660444;Q408580;LATREPIRDINE [WHO-DD];1H-PYRIDO(4,3-B)INDOLE, 2,3,4,5-TETRAHYDRO-2,8-DIMETHYL-5-(2-(6-METHYL-3-PYRIDINYL)ETHYL)-;NCGC00182554-04;2,3,4,5-Tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-1H-pyrido[4,3-b]indole;BDBM50305261;J-520335;9-(2-(2-Methyl-5-pyridyl)ethyl)-3,6-dimethyl-1,2,3,4-tetrahydro-.gamma.-carboline;2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole;CHEBI:92976;DTXSID20189705;2,3,4,5-tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridyl)ethyl]-1H-pyrido[4,3-b]indole;Latrepirdine; Dimebolin;BRD-K55703048-300-01-6;1H-Pyrido[4,3-b]indole,2,3,4,5-tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-;1227953-42-5;DB-260452;GLXC-10857;BRD-K55703048-001-07-7;DB-069323;

标识符

MDL：

MFCD00387540

InChIKey：

JNODQFNWMXFMEV-UHFFFAOYSA-N

Inchi：

1S/C21H25N3/c1-15-4-7-20-18(12-15)19-14-23(3)10-9-21(19)24(20)11-8-17-6-5-16(2)22-13-17/h4-7,12-13H,8-11,14H2,1-3H3

SMILES：

N1(CCC2C=NC(C)=CC=2)C2C=CC(C)=CC=2C2CN(C)CCC1=2

2,3,4,5-四氢-2,8-二甲基-5-[2-(6-甲基吡啶-3-基)乙基]-1H-吡啶并[4,3-b]吲哚(3613-73-8)物化性质

实验特性

LogP : 3.82160
PSA : 21.06000
折射率 : 1.6380 (estimate)
沸点 : 448.46°C (rough estimate)
闪点 : 259.7ºC
密度 : 1.13

计算特性

精确分子量 : 319.20500
氢键供体数量 : 0
氢键受体数量 : 3
可旋转化学键数量 : 3
同位素质量 : 319.205
重原子数量 : 24
复杂度 : 425
同位素原子数量 : 0
确定原子立构中心数量 : 0
不确定原子立构中心数量 : 0
确定化学键立构中心数量 : 0
不确定化学键立构中心数量 : 0
共价键单元数量 : 1
疏水参数计算参考值（XlogP） : 3.5
拓扑分子极性表面积 : 21.1A^2

2,3,4,5-四氢-2,8-二甲基-5-[2-(6-甲基吡啶-3-基)乙基]-1H-吡啶并[4,3-b]吲哚(3613-73-8)推荐厂家更多厂家(18)

公司名称	手机号/电话	联系人	QQ	询单
上海绩祥生物科技有限公司	13093077543	陆经理	3985448220	询单
上海一基实业有限公司	13311756052 021-60526763 13311756052 13311756131	胡经理	2355265332	询单
上海一基实业有限公司	13311756131 021-60548336 QQ：2355265332 QQ:2851717387	胡经理	2355265332	询单
上海瀚思化工有限公司	18939883912 021-34536277	顾经理	3003949364	询单
金锦乐（湖南）化学有限公司		金锦乐	1226360695	询单
赫澎（上海）生物科技有限公司	13122891558 186-16545970	张硕	3418426269	询单
上海依赫生物科技有限公司	17721395025 021-68882955	张经理	2423903095	询单
北京索莱宝科技有限公司	17812059581 010-50973134	龚思雨	2748554845	询单
江苏艾康生物医药研发有限公司	18795912720 025-66061636	杨情情	3004779232	询单
上海麦克林生化科技股份有限公司	15221275939 021-50706066	沈经理	269348414	询单

2,3,4,5-四氢-2,8-二甲基-5-[2-(6-甲基吡啶-3-基)乙基]-1H-吡啶并[4,3-b]吲哚(3613-73-8)相关文献

1. Two diseases, one approach: multitarget drug discovery in Alzheimer's and neglected tropical diseases
F. Prati,E. Uliassi,M. L. Bolognesi Med. Chem. Commun. 2014 5 853
2. Computational analyses of mechanism of action (MoA): data, methods and integration
Maria-Anna Trapotsi,Layla Hosseini-Gerami,Andreas Bender RSC Chem. Biol. 2022 3 170
3. Two decades of new drug discovery and development for Alzheimer's disease
Zhidong Liu,Aihua Zhang,Hui Sun,Ying Han,Ling Kong,Xijun Wang RSC Adv. 2017 7 6046
4. Novel base-initiated cascade reactions of hemiindigos to produce dipolar γ-carbolines and indole-fused pentacycles
V. S. Velezheva,O. L. Babii,A. A. Khodak,E. A. Alekseeva,Yu V. Nelyubina,I. A. Godovikov,A. S. Peregudov,K. B. Majorov,B. V. Nikonenko RSC Adv. 2019 9 41402
5. Constructions of tetrahydro-γ-carboline skeletons via intramolecular oxidative carbon–carbon bond formation of enamines
Jinglei Lv,Ji Li,Daisy Zhang-Negrerie,Siyun Shang,Qingzhi Gao,Yunfei Du,Kang Zhao Org. Biomol. Chem. 2013 11 1929
6. Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease
Sophie Laurent,Mohammad Reza Ejtehadi,Meisam Rezaei,Patrick G Kehoe,Morteza Mahmoudi RSC Adv. 2012 2 5008
7. Effects of piceatannol and pterostilbene against β-amyloid-induced apoptosis on the PI3K/Akt/Bad signaling pathway in PC12 cells
Zheng Fu,Jiufang Yang,Yangji Wei,Jingming Li Food Funct. 2016 7 1014
8. Effects of piceatannol and pterostilbene against β-amyloid-induced apoptosis on the PI3K/Akt/Bad signaling pathway in PC12 cells
Zheng Fu,Jiufang Yang,Yangji Wei,Jingming Li Food Funct. 2016 7 1014

20674-92-4(2,3,4,5-四氢-5-(2-(6-甲基-3-吡啶基)乙基)-2-丙基-1H-吡啶并(4,3-b)吲哚) 16566-78-2(1H-吡啶并[4,3-b]吲哚，2-丁基-2,3,4,5-四氢-5-[2-（4-吡啶基）乙基]-) 20674-94-6(2,3,4,5-四氢-2-丁基-5-(2-(6-甲基-3-吡啶)乙基)-1H-吡啶并(4 ,3-b)吲哚) 81568-09-4(5-Chloro-2-dimethylaminopyrimidine) 816448-94-9(6-METHYLQUINOLINE-4-CARBOXYLIC ACID) 81540-86-5((8Z,11Z,14Z)-(8,9,11,12,14,15-2H6)-8,11,14-Icosatrienoic acid) 81597-51-5(5-溴-4-甲基-2-噻吩磺酰氯) 816-16-0(2-Ethylpentanoic acid methyl ester)

问答

急需2,3,4,5-四氢-2,8-二甲基-5-[2-(6-甲基吡啶-3-基)乙基]-1H-吡啶并[4,3-B]吲哚 ,CAS号 3613-73-8各种规格及其价格。

960化工网为您提供2,3,4,5-四氢-2,8-二甲基-5-[2-(6-甲基吡啶-3-基)乙基]-1H-吡啶并[4,3-b]吲哚专业化合物百科信息，包括中文名，英文名，分子式，分子量，以及该化合物的CasNo.3613-73-8,相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等。 WAP版:3613-73-8 国际站:3613-73-8